Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Cepheid, Sherlock Biosciences Partner on SARS-CoV-2 Diagnostic Test

Cepheid, Sherlock Biosciences Partner on SARS-CoV-2 Diagnostic Test

Feb 28, 2020
|
staff reporter

NEW YORK – Cepheid and Sherlock Biosciences said on Friday that they have formed a research collaboration to develop new molecular diagnostic tests, using Sherlock Biosciences' CRISPR-based engineering biology platform SHERLOCK to design tests to run on Cepheid's GeneXpert systems.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Open at Publication

Howard Hughes Medical Institute will be requiring its researchers to publish their work so it is immediately accessible to the public, ScienceInsider writes.

Truth and Science

The Huffington Post reports that Francis Collins, the director of the US National Institutes of Health, has urged Americans to recommit to reason.

Quick Tests to Be Given Out

About 150 million rapid coronavirus tests purchased by the US federal government are to be distributed to nursing homes, colleges, and the states, according to the New York Times.

Nature Papers Examine Molecular Pathways in Alzheimer's Disease, Diploid Potato Assembly, More

In Nature this week: multi-omic analysis of Alzheimer's disease brain samples, de novo assembly of a diploid potato, and more.

What's Popular?

In Business News

  1. Sophia Genetics Closes $110M Series F Funding Round

  2. Bruker Acquires Software Platform From Integrated Proteomics Applications

  3. CareDx Shares Spike as AlloSure Heart Transplant Test Garners Final LCD From Palmetto

  4. BioGX BV Gets CE-IVD Mark for Coronavirus, Flu, RSV Combo Test

  5. Quidel Releases Preliminary Q3 Results, Partners with Biodesix for Big Ten Surveillance

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.